Kjersti Kirkeby is an Endocrinology/Metabolic physician affiliated with California Pacific Medical Center. OpenAlex indexes 34 publications with 567 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1100 Van Ness Ave
San Francisco, CA 941096978
Telephone
415-600-0110Provider last certified this registry record 27 Apr 2021.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Tandem Diabetes Care, Inc.Program year20241 payment
- Dexcom, Inc.Program year20241 payment
- Medtronic, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
71.7%GLP-1 receptor agonist22.8%Ozempic62%Mounjaro24%Trulicity8%Rybelsus5%Part D<11 patientsInsulin Analog16.7%Tresiba Flextouch U-10019%Basaglar Kwikpen U-10018%Lantus Solostar15%Tresiba Flextouch U-2009%Fiasp Flextouch8%Humalog Kwikpen U-1007%Insulin Lispro Kwikpen U-1007%Novolog6%Novolog Flexpen5%Humalog Junior Kwikpen4%Humalog Kwikpen U-2003%Part D<11 patients+ 6 more classes in this area
Cardiovascular
18.4%Statin10.1%Atorvastatin Calcium72%Rosuvastatin Calcium18%Pravastatin Sodium10%Part D<11 patientsAngiotensin receptor blocker (ARB)2.5%Losartan Potassium100%Part D≥24 patients+ 5 more classes in this area
Hormonal (systemic)
9.2%l-Thyroxine7.4%Levothyroxine Sodium69%Synthroid31%Part D≥47 patientsThyroid Hormone Synthesis Inhibitor1.5%Methimazole100%Part D≥11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- SUN-407 Adrenal Abscess in a Patient with Disseminated Nocardiosis: A Case Report
Journal of the Endocrine Society
2025 - 8299 A Case of Hypoglycemia in a Patient with Cirrhosis and Previous Bariatric Surgery
Journal of the Endocrine Society
2024 - PSAT388 A Rapidly progressive papillary thyroid carcinoma presenting 22 years after RAI therapy
Journal of the Endocrine Society
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Emmett Cunningham, MD, PhD, MPH
California Pacific Medical Center
John Chan, MD
California Pacific Medical Center
Kenneth Binmoeller, MD
California Pacific Medical Center
Yvonne Cheng, MD
California Pacific Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”